Adeno-associated virus (AAV) is a classification given to a group of nonpathogenic, single-stranded DNA viruses known to reside latently in primates. During latency in humans, AAV type 2 (AAV2) preferentially integrates at a site on chromosome 19q13.3ter by targeting a sequence composed of an AAV Rep binding element (RBE), a spacer, and a nicking site. Here, we report the DNA sequence of an African green monkey AAV integration site isolated from CV-1 cells. Overall, it has 98% homology to the analogous human site, including identical spacer and nicking sequences. However, the simian RBE is expanded, having five perfect directly repeated GAGC tetramers. We carried out a number of in vitro and in vivo assays to determine the effect of this expanded RBE sequence on the Rep-RBE interaction and AAV targeted integration. Using electromobility shift assays it was demonstrated that AAV4 Rep68 bound the expanded RBE with a sixfold-greater affinity than the human RBE. To determine the basis for the affinity increase, DNase I protection and methylation interference (MI) assays were performed. Comparison of footprints on both the human and simian RBEs revealed nearly identical protection; however, MI analysis suggested greater interaction with the guanine nucleotides of the expanded RBE, thus providing a biochemical basis for the increased binding activity. In vivo, integration targeted to the simian RBE was demonstrated by PCR analysis of latently infected Cos-7 cells. Interestingly, the frequency of site-specific integration was twofold greater in Cos-7 cells than in HeLa cells. Overall, these experiments establish that the simian RBE, identified in CV-1 cells, functions analogously to the human RBE and provide further evidence for a developing model that proposes individual roles for the RBE and the spacer and nicking site elements.To date, eight different but closely related adeno-associated virus (AAV) serotypes (types 1 to 8) which infect primates have been identified (reviewed in references 6 and 16). These viruses are members of the family Parvoviridae, and they have a unique biology that makes them particularly well suited as gene therapy vectors (1,6,16,35,(42)(43)(44). Additionally, AAV (specifically type 2 [AAV2]) has been shown to be the only known mammalian virus having the potential to site-specifically integrate into the human genome, preferentially targeting a site on human chromosome 19q13.3qter (ch19) (6,9,20,21,25,33,34,41) The AAV genome is composed of linear single-stranded DNA ϳ4.7 kb long (42, 49), and while AAV2 is the most thoroughly characterized AAV, studies of other serotypes are under way (10, 12, 38). These include monkey-specific AAV4, which was recently cloned and found to have a high degree of homology to AAV2 (12). The AAV4 genome has two open reading frames, like that of AAV2, and codes for similar Rep proteins (Rep78 [78 kDa], -68, -52, and -40). For example, the AAV4 Rep68 protein has 90% amino acid identity to AAV2 Rep68, with 5% of the divergent amino acids being similar in hydrophobi...